Form 10-12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0001047469-13-010050
Filing Date
2013-10-29
Accepted
2013-10-29 17:13:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 10-12B/A a2217160z10-12ba.htm 10-12B/A 54815
2 EX-99.1 a2217160zex-99_1.htm EX-99.1 1303727
3 G817752.JPG g817752.jpg GRAPHIC 6750
4 G814105.JPG g814105.jpg GRAPHIC 113248
  Complete submission text file 0001047469-13-010050.txt   1525169
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-12B/A | Act: 34 | File No.: 001-36033 | Film No.: 131177116
SIC: 2834 Pharmaceutical Preparations